Lung cancer is a cancer that starts in the lungs. It is the second most common cancer in both men (after prostate cancer) and women (after breast cancer). It accounts for about 15 percent of all new cancers.
Most lung cancers are "non-small cell" lung cancer (NSCLC). A small percentage (about 13 percent) is "small cell" lung cancer, which tends to spread more quickly than NSCLC.
Legacy's team of outstanding specialists will work together to evaluate your case and develop a personalized treatment plan for you. At Legacy we understand that you have a life, not just a diagnosis.
Legacy ranks among the nation's top cancer programs and has received multiple quality awards including the Outstanding Achievement Award from the American College of Surgeons' Commission (ACS) on Cancer. The ACS ranks Legacy's cancer program as one of the best in the nation.
Physician case review
Our multidisciplinary cancer care conferences review complex cases to provide an expert "second opinion" on diagnosis, pre-treatment evaluation, staging, treatment strategy and rehabilitation. The team includes pulmonologists, medical oncologists, pathologists, radiation oncologists, radiologists, surgeons, nurses, research coordinators and other cancer care staff.
You're not alone
At the Legacy Cancer Institute we offer services to support every aspect of your treatment including your physical, emotional, social and spiritual well-being. We offer a wide range of support services to help you and your family. If you need help just ask us, and we'll help you find the support you need.
Our personalized support services begin with our nurse navigators. They will help you throughout your treatment, from knowing what to expect to finding the right support services and helping you manage symptoms and treatment side effects. Contact a nurse navigator.
In addition, the following support services are also available: